Benzinga | Feb 19, 2021 07:23AM EST

Barclays Reinstates Overweight on Molina Healthcare, Announces $260 Price Target

Barclays analyst Steven Valiquette reinstates Molina Healthcare (NYSE:MOH) with a Overweight and announces $260 price target.